NutriBand (NTRB) Non-Current Deferred Tax Liability (2020 - 2021)
NutriBand's (NTRB) quarterly Non-Current Deferred Tax Liability came in at $525000.0 in Q1 2021, little changed year-on-year from $525000.0 in Q1 2020, and little changed quarter-over-quarter from $525000.0 in Q1 2020.
NutriBand (NTRB) Non-Current Deferred Tax Liability (2020 - 2021) Analysis & Trends
NutriBand has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $525000.0 for Q1 2021.
- Non-Current Deferred Tax Liability for Q1 2021 came in at $525000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jan 2021 was $525000.0 (changed 0.0% YoY), and the FY2021 annual result was $525000.0, changed 0.0% from the prior year.
- Non-Current Deferred Tax Liability came in at $525000.0 for Q1 2021 at NutriBand, roughly flat from $525000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $525000.0 in Q1 2020 to a low of $525000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 525,000.00 |
| Jan 31, 2021 | 525,000.00 |
| Jan 31, 2020 | 525,000.00 |
| Jan 31, 2020 | 525,000.00 |